Clinical Trials · NCT06634927
Pharmacokinetic Similarity, Safety, and Immunogenicity of Semaglutide Injection and Ozempic ® Injection in Healthy Subjects.
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
- Enrollment
- 68
- Start date
- Sep 2024
- Locations
- 1 site, China
- Primary endpoint
- AUC0-inf